title: Pediatric Clostridium difficile: a phantom menace or clinical reality?
authors.affiliation: Department of Medicinal Chemistry, University of Washington, Seattle, USA. lvmcfarl@u.washington.edu
authors.forename: L V
authors.initials: LV
authors.lastname: McFarland
authors.forename: S A
authors.initials: SA
authors.lastname: Brandmarker
authors.forename: S
authors.initials: S
authors.lastname: Guandalini
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D016360:Clostridioides difficile / Q000254:growth & development / Q000302:isolation & purification*; D003428:Cross Infection / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D003603:Cytotoxins / Q000096:biosynthesis; D003967:Diarrhea; D004196:Disease Outbreaks / Q000517:prevention & control; D004761:Enterocolitis, Pseudomembranous / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D008297:Male; D015995:Prevalence; D012307:Risk Factors
chemical_list: D003603:Cytotoxins